Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).

PubWeight™: 2.23‹?› | Rank: Top 2%

🔗 View Article (PMID 18268174)

Published in Arch Intern Med on February 11, 2008

Authors

Tiny Jaarsma1, Martje H L van der Wal, Ivonne Lesman-Leegte, Marie-Louise Luttik, Jochem Hogenhuis, Nic J Veeger, Robbert Sanderman, Arno W Hoes, Wiek H van Gilst, Dirk J A Lok, Peter H J M Dunselman, Jan G P Tijssen, Hans L Hillege, Dirk J van Veldhuisen, Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH) Investigators

Author Affiliations

1: Department of Cardiology, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB Groningen; the Netherlands.

Associated clinical trials:

NCT98675639

Articles citing this

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol (2010) 3.50

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med (2010) 2.21

Effect of home-based telemonitoring using mobile phone technology on the outcome of heart failure patients after an episode of acute decompensation: randomized controlled trial. J Med Internet Res (2009) 2.17

A randomized trial of home telemonitoring in a typical elderly heart failure population in North West London: results of the Home-HF study. Eur J Heart Fail (2009) 1.55

Telomere biology in healthy aging and disease. Pflugers Arch (2009) 1.41

Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides. Neth Heart J (2016) 1.38

Evaluation of a large scale implementation of disease management programmes in various Dutch regions: a study protocol. BMC Health Serv Res (2011) 1.25

Case management for patients with chronic systolic heart failure in primary care: the HICMan exploratory randomised controlled trial. Trials (2010) 1.19

Cognitive impairment is independently associated with reduced instrumental activities of daily living in persons with heart failure. J Cardiovasc Nurs (2011) 1.09

Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting. Eur Heart J (2013) 1.04

The management of cardiovascular disease in the Netherlands: analysis of different programmes. Int J Integr Care (2013) 1.02

The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs. Can J Cardiol (2010) 1.00

Association between having a caregiver and clinical outcomes 1 year after hospitalization for cardiovascular disease. Am J Cardiol (2011) 0.98

Self-reported versus 'true' adherence in heart failure patients: a study using the Medication Event Monitoring System. Neth Heart J (2012) 0.96

Neurohormonal profile of patients with heart failure and diabetes. Neth Heart J (2010) 0.92

Outcomes for mitral valve surgery among Medicare fee-for-service beneficiaries, 1999 to 2008. Circ Cardiovasc Qual Outcomes (2012) 0.91

Specialized multi-disciplinary heart failure clinics in Ontario, Canada: an environmental scan. BMC Health Serv Res (2012) 0.91

A meta-review of evidence on heart failure disease management programs: the challenges of describing and synthesizing evidence on complex interventions. Trials (2011) 0.90

Cost-effectiveness of heart failure therapies. Nat Rev Cardiol (2013) 0.89

Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink). Eur J Heart Fail (2011) 0.88

Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides. Cardiovasc Diabetol (2010) 0.88

Transitional Care for Patients With Congestive Heart Failure: A Systematic Review and Meta-Analysis. Ann Fam Med (2015) 0.86

Renal dysfunction is associated with shorter telomere length in heart failure. Clin Res Cardiol (2009) 0.85

Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement. Int J Cardiol (2016) 0.85

The post-infarction nurse practitioner project: A prospective study comparing nurse intervention with conventional care in a non-high-risk myocardial infarction population. Neth Heart J (2009) 0.84

Tailoring of self-management interventions in patients with heart failure. Curr Heart Fail Rep (2015) 0.84

Risk stratification for death and all-cause hospitalization in heart failure clinic outpatients. Am Heart J (2013) 0.83

Multidisciplinary intensive education in the hospital improves outcomes for hospitalized heart failure patients in a Japanese rural setting. BMC Health Serv Res (2014) 0.83

The value of INnovative ICT guided disease management combined with Telemonitoring in OUtpatient clinics for Chronic Heart failure patients. Design and methodology of the IN TOUCH study: a multicenter randomised trial. BMC Health Serv Res (2011) 0.82

Do Self-Management Interventions Work in Patients With Heart Failure? An Individual Patient Data Meta-Analysis. Circulation (2016) 0.82

Design and methodology of the COACH-2 (Comparative study on guideline adherence and patient compliance in heart failure patients) study: HF clinics versus primary care in stable patients on optimal therapy. Neth Heart J (2012) 0.81

HerzMobil Tirol network: rationale for and design of a collaborative heart failure disease management program in Austria. Wien Klin Wochenschr (2014) 0.81

Stratifying patients at the risk of heart failure hospitalization using existing device diagnostic thresholds. Heart Lung (2014) 0.80

The study of health coaching: the ithaca coaching project, research design, and future directions. Glob Adv Health Med (2013) 0.80

Perceived barriers of heart failure nurses and cardiologists in using clinical decision support systems in the treatment of heart failure patients. BMC Med Inform Decis Mak (2013) 0.80

Understanding palliative care on the heart failure care team: an innovative research methodology. J Pain Symptom Manage (2012) 0.80

Association between Spirituality and Adherence to Management in Outpatients with Heart Failure. Arq Bras Cardiol (2016) 0.79

Cost-effectiveness of a nurse-led education and psychosocial programme for patients with chronic heart failure and their partners. J Clin Nurs (2013) 0.78

Heart failure patients' descriptions of participation in structured home care. Health Expect (2013) 0.78

What is the impact of systems of care for heart failure on patients diagnosed with heart failure: a systematic review. BMC Cardiovasc Disord (2016) 0.78

Heart failure, aging and beta-blockers: the need for more data on tolerability and efficacy. Clin Res Cardiol (2008) 0.78

Improvement of primary care for patients with chronic heart failure: a pilot study. BMC Health Serv Res (2010) 0.77

What Are Effective Program Characteristics of Self-Management Interventions in Patients With Heart Failure? An Individual Patient Data Meta-analysis. J Card Fail (2016) 0.75

Evaluation of a Community Health Service Center-Based Intervention Program for Managing Chronic Heart Failure. Balkan Med J (2016) 0.75

Remote monitoring of heart failure patients. Methodist Debakey Cardiovasc J (2013) 0.75

Heart failure. BMJ Clin Evid (2011) 0.75

A Strategy to Reduce Heart Failure Readmissions and Inpatient Costs. Cardiol Res (2015) 0.75

A window of opportunity: improving cardiovascular health in women. Neth Heart J (2009) 0.75

Heart failure. BMJ Clin Evid (2010) 0.75

Interactive Digital e-Health Game for Heart Failure Self-Management: A Feasibility Study. Games Health J (2016) 0.75

Strategies to Modify the Risk of Heart Failure Readmission: A Systematic Review and Meta-Analysis. Health Serv Res Manag Epidemiol (2017) 0.75

Does case management for patients with heart failure based in the community reduce unplanned hospital admissions? A systematic review and meta-analysis. BMJ Open (2016) 0.75

Reducing Heart Failure Hospital Readmissions: A Systematic Review of Disease Management Programs. Cardiol Res (2014) 0.75

Cognitive status in patients hospitalized with acute decompensated heart failure. Am Heart J (2014) 0.75

Practical guide on home health in heart failure patients. Int J Integr Care (2013) 0.75

Disease management in the treatment of patients with chronic heart failure who have universal access to health care: a randomized controlled trial. BMC Med (2017) 0.75

Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction. J Am Heart Assoc (2017) 0.75

Low circulating microRNA levels in heart failure patients are associated with atherosclerotic disease and cardiovascular-related rehospitalizations. Clin Res Cardiol (2017) 0.75

Articles by these authors

Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med (2013) 20.65

Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med (2010) 14.43

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73

Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J (2008) 12.32

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med (2002) 8.72

A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med (2002) 8.37

Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med (2010) 8.17

Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med (2005) 7.80

Rosuvastatin in older patients with systolic heart failure. N Engl J Med (2007) 7.55

Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation (2002) 7.25

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail (2008) 6.80

Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int (2004) 6.32

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J (2013) 6.17

Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med (2004) 6.00

Antibiotics for acute otitis media: a meta-analysis with individual patient data. Lancet (2006) 5.83

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J (2013) 5.23

Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med (2013) 4.67

Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med (2002) 4.33

Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. J Clin Oncol (2007) 4.19

Clinical epidemiology of heart failure. Heart (2007) 4.11

Global incidences of out-of-hospital cardiac arrest and survival rates: Systematic review of 67 prospective studies. Resuscitation (2010) 3.98

Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail (2010) 3.90

Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet (2013) 3.87

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation (2006) 3.85

Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol (2011) 3.66

Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J (2005) 3.58

Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet (2010) 3.55

B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol (2013) 3.54

Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure. J Am Coll Cardiol (2005) 3.53

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol (2010) 3.50

Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure. Am J Med (2013) 3.46

Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). J Am Coll Cardiol (2009) 3.32

Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol (2009) 3.31

Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation (2002) 3.27

The Wells rule does not adequately rule out deep venous thrombosis in primary care patients. Ann Intern Med (2005) 3.21

New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 3.14

A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J (2009) 3.06

Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04

Common variants near TERC are associated with mean telomere length. Nat Genet (2010) 2.98

Presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention. Circulation (2008) 2.96

Diagnostic accuracy of combined intracoronary pressure and flow velocity information during baseline conditions: adenosine-free assessment of functional coronary lesion severity. Circ Cardiovasc Interv (2012) 2.93

Randomized trial comparing same-day discharge with overnight hospital stay after percutaneous coronary intervention: results of the Elective PCI in Outpatient Study (EPOS). Circulation (2007) 2.90

Distress in couples coping with cancer: a meta-analysis and critical review of role and gender effects. Psychol Bull (2008) 2.87

Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease. Arch Intern Med (2010) 2.82

Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J (2005) 2.81

Seventy-five genetic loci influencing the human red blood cell. Nature (2012) 2.77

Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail (2007) 2.77

Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J (2005) 2.74

Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria. EuroIntervention (2016) 2.67

Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail (2010) 2.64

Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. Eur Heart J (2010) 2.62

Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol (2008) 2.59

Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia. Eur Heart J (2007) 2.59

A single dose of erythropoietin in ST-elevation myocardial infarction. Eur Heart J (2010) 2.52

Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial. J Clin Oncol (2010) 2.51

Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study. J Am Coll Cardiol (2010) 2.50

The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study. Nephrol Dial Transplant (2006) 2.50

Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J (2013) 2.45

Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome. Eur Heart J (2004) 2.44

Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med (2006) 2.42

Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ Res (2009) 2.41

Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation (2010) 2.41

Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am J Psychiatry (2006) 2.41

Effectiveness of a multiple intervention to reduce antibiotic prescribing for respiratory tract symptoms in primary care: randomised controlled trial. BMJ (2004) 2.41

Safe exclusion of pulmonary embolism using the Wells rule and qualitative D-dimer testing in primary care: prospective cohort study. BMJ (2012) 2.38

2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J (2010) 2.36

Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol (2007) 2.36

Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation (2006) 2.35

Microalbuminuria and risk of venous thromboembolism. JAMA (2009) 2.35

Comparing the diagnostic performance of 2 clinical decision rules to rule out deep vein thrombosis in primary care patients. Ann Fam Med (2011) 2.34